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ABSTRACT
This research work is composed of two projects: namely, 
chemical synthesis of 3-hydroxykynurenine glucoside, an important 
lens metabolite and; examining, with the aid of capillary 
electrophoresis and electrospray mass spectrometry, the serine loss 
of the C-terminal extensions of bovine aA and pB2 lens crystallins in 
order to determine whether any age related degradation occurs.
3-Hydroxykynurenine glucoside is a compound present in 
human lens. The function of this chemical is as yet unknown, 
however, it is possible that it may play a role as a UV filter 
compound preventing damage to the lens. The study of 3- 
hydroxykynurenine glucoside has been restricted by the limited 
amount of this compound that can be obtained from lenses. In this 
project, the synthesis aims to supply sufficient compound in order to 
make more further detailed study of 3-hydroxykynurenine glucoside 
possible.
Both capillary electrophoresis and electrospray mass
spectrometry are new analytical techniques which came into general 
use in the 90's. This project utilises the high resolution and accuracy 
of these methods to confirm a serine loss from C-terminal extensions 
of aA and pB2 crystallins with ageing. The C-terminal extensions of 
a  A and PB2 crystallins consist of 8 (a A) and 11 (pB2) amino acid
residues, and they may play a major role in the formation of lens 
crystallin aggregations. This arrangement of the crystallin is crucial 
to the maintenance of lens transparency and its disruption can lead 
to opacification of the lens (Carver et al.y 1992). Recent work has 
found the terminal extensions have great flexibility compared with 
the bulk of the protein making them digestible by enzymes present 
in the lens. Confirmation of a serine loss from aA and |3B2 crystallins 
and that this serine loss occurs at the C-terminal extensions. This 
suggests the presence of a carboxypeptidase A like enzyme in the 
lens digests these proteins throughout life.
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1.1. The eye and lens
Fig. 1 Diagrammatic section through the eye.
Fig. 1 shows the structure of the eye. The light which is 
transmitted by the eye passes through the cornea, aqueous 
humour, lens and vitreous body, before reaching the retina. 
During this process, the lens, which is suspended between the 
aqueous body by zonular ligaments, filters, transmits and focuses 
the light onto the retina. Fig. 2 shows the unique structure of the 
lens. Some special properties are associated with this structure. 
For example, in the lens the newly formed younger cells crowd 
around older cells, as a result of this, there is no cell loss from the 
lens, leading to lens growth throughout life. Another property of
2
the lens is the absence of cell nuclei, DNA and RNA, hence the lens’ 
cell metabolic pathways differ markedly from normal tissue cells, 
particularly with respect to protein renewal. Consequently, there 
are a number of different types of post-translational modifications 
to lens proteins associated with both aging of the lens and the 
onset of diseases such as cataract (Harding, 1991).
Cortex ipithelium Anterior
Equato
Fig. 2. Diagrammatic section through the lens.
1.2 3 -H ydroxy  kyn uren i n e g lucoside: A low m o lecu la r 
weight compound in the hum an lens
In the primate lens, three low molecular compounds have 
been identified as 3-hydroxykynurenine,  3 -hydroxykynurenine 
glucoside, and L-kynurenine using protein-free extraction and 
HPLC analysis methods (Fig. 3). Of these three compounds, 3- 
hydroxykynurenine glucoside represents the major species (van 
H eyn ingen ,  1973; Wood and Trusco tt ,  1993). 3-Hydroxy  
k y n u ren in e  g lucos ide ,  which gives a s trong b lue-w hi te  
fluorescence, was first separated from the human lens by van 
































SCHEME 1. The 3-hydroxykynurenine glucoside 
pathway of tryptophan metabolism
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and the compound was identified by cleaving the glucoside using 
hydrolysis with ß-glucosidase or 1 M hydrochloric acid to give 3- 
hydroxykynurenine and D-glucose (van Heyningen, 1971a, b). 
Later this ß-glucosidase hydrolysis experiment was repeated by 
Brando et al. (1981) and 3-hydroxykynurenine and glucose were 
identified by amino acid analysis and gas chromatography (GC) 
respectively .
Fig. 3 HPLC chromatogram of the protein-free extract of the human lens. The 
detecting wavelength is 365 nm. The numbers above the peaks are retention times in 
minutes. The compounds were shown to be 3-hydroxykynurenine (14.7 min), 3-
5
hydroxy-kynurenine glucoside (17.1 min) and kynurenine (29.7 min). This fig. is 
reproduced from Wood and Truscott (1993).
1.3 3-H ydroxykynurenine glucoside: a m etabolic product 
of tryptophan
Scheme 1 shows the major metabolic pathway of tryptophan 
in mammals. In step 1, the indole ring of tryptophan is cleaved. In 
the liver, this step is catalysed by an inducible enzyme, indole 
amine dioxygenase, which forms L-N'-formylkynurenine. 
(Feigekson and Greengard, 1961). The same product is formed in 
other organs by the enzyme indoleamine-2,3-dioxygenase 
(Hayaishi, 1971). The N’-formylkynurenine is hydrolysed by 
formamidase in step 2 to give kynurenine (Knox and Mehler, 
1950). In step 3, the enzyme kynurenine 3-monooxygenase is 
responsible for the hydroxylation of kynurenine at position 3 
(Okamoto et al. 1967). In step 4, 3-hydroxykynurenine is cleaved 
by kynureninase to 3-hydroxyanthranilic acid and alanine 
(Hayaishi and Okamoto, 1971). In step 5, a lens specific reaction is 
shown, in which 3-hydroxykynurenine is conjugated with glucose 
to form 3-hydroxykynurenine glucoside. The mechanism of this 
reaction is not yet clear. Until now, only two glucosides have been 
found in mammalian tissues. One is 3-hydroxykynurenine 
glucoside which is found in the lens (van Heyningen, 1971 a) and 
the other is bilirubin glucoside (Fevery et al. 1971) which has 
been identified in bile. The existence of these glucosides provides 
evidence that mammals can form glucosides as well as 
glucuronides.
It is believed that the tryptophan metabolism and glucoside 
formation both take place in the layer of epithelial cells on the
6
anterior surface of the lens. In their recent research, Wood and 
Truscott (1993) proposed a model which suggested that 3- 
hydroxykynurenine glucoside was synthesised in the epithelial 
cells, and possibly the cortical region, and then diffused 
throughout the remainder of the lens. It is believed that the 
formation of the glucoside is via a uridine diphosphate glucose 




1.4 The m ajor role of 3-hydroxykynurenine glucoside in 
the prim ate lens
Surprisingly little research has been performed on the role 
of 3-hydroxykynurenine glucoside in the lens, despite its potential 
importance in the lens. The first measurements of the UV 
absorption of the yellow substances obtained from human lens 
were performed by Walls (1942) and Cooper et al. (1969) who 
p u rified  these w ate r-so lu b le  yellow  substances by
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chromatography, finding a fast-moving component with a blue 
fluorescence and maximum UV absorption at 365nm. However, it 
was not until van Heyningen (1971a) first identified this yellow 
compound as 3-hydroxykynurenine glucoside, that the some of 
the functions of this compound has been gradually revealed.
Based on the principle that 3-hydroxykynurenine glucoside 
can absorb light in the 300-400nm band (with a maximum at 
365nm), it is possible that the major role of 3-hydroxykynurenine 
glucoside in human lenses is to eliminate the near-ultraviolet 
band as light passes through cornea. The cornea filters out all light 
below 300nm. This function of absorbing the near-ultraviolet light 
may protect the human lens.
Secondly, Dillon and Atherton (1990) found that the excited 
state of 3-hydroxykynurenine glucoside decays rapidly and acted 
as a relatively inefficient sensitising agent for lens proteins. 
Hence, another role of 3-hydroxykynurenine glucoside could be to 
minimise photochemical insult to the lens.
Finally, recent work has demonstrated that 3-hydroxy­
kynurenine glucoside effluxes continuously from human lenses 
(Wood and Truscott, 1993) and it is possible that it may play an 
unknown signalling role in the eye.
Further work on the role of 3-hydroxykynurenine glucoside 
has in part been restricted by the lack of synthetic material 
available. Until now, all of the 3-hydroxykynurenine glucoside 
used in this area of research has been isolated from lenses by 
extraction followed by electrophoresis (van Heyningen, 1971b) or 
purification by way of a Sephadex G-15 column (Bando et al.
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1980). The approximate concentration of 3-hydroxykynurenine 
glucoside in the lens is only 1.54 pmol/g lens (van Heyningen, 
1973a), which making this isolation a formidable task.
Thus a major aim of this work is to chemically synthesise 3- 
hydroxykynurenine glucoside to enable more effective research 
about the function of 3-hydroxykynurenine glucoside in human 
lens to be conducted.
1.5. Lens crystallins
Many physical and pathological changes take place in the 
lens with age. Some changes are obvious, such as increasing 
weight, thickness and yellowness, and decreasing accommodative 
power (presbyopia). Other changes, such as peripheral opacities, 
increasing fluorescence, decreasing activities of a variety of 
enzymes and increasing post-translational modification of the lens 
proteins (the crystallins), are not so obvious. Some of these 
changes, which involve lens proteins (Harding, 1991), are 
observable to a greater extent in cataract and are thought to be 
responsible for the increased opacity of the lens with cataract.
The lens contains a high concentration of structural proteins 
which comprise approximately 35% of the whole lens by weight. 
Lens proteins may be subdivided into two groups, the water- 
soluble crystallins and a water-insoluble fraction (van Heyningen, 
1973a). The particular structural arrangement of these lens 
proteins is responsible for the transmission and focussing of light 
onto the retina.
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With size exclusion gel chromatography (Kleimam et al., 
1988), the water-soluble mammalian lens proteins can be 
separated in order as aggregated protein (HM), a-crystallins, pH-, 
pLi, pL2-crystallins, and Ys-, Y-crystallins. The aggregated protein, 
which is also called high-molecular-weight protein, has a 
molecular weight greater than a million. Chiou and Azari (1989); 
Liang and Rossi (1989) found in bovine lens this aggregated 
protein appeares to be a partly unfolded form of a-crystallins. a- 
crystallins and p-crystallins are present as high aggregates (a- 
crystallins), octomers (pH-crystallin), trimers (pLl-crystallin) and 
dimers (pL2-crystallin) which form the major part of the lens 
protein, a-Crystallins are composed of two closely related 
subunits aA and aB. Both of these subunits have a molecular 
weight of approximately 20 kDa. The p-crystallins are composed 
of three basic subunits and four acidic subunits whose molecular 
masses range from 23 to 33 kDa. y-Crystallins are monomers with 
molecular masses of about 20 kDa. (Harding, et al., 1976; Harding, 
1992).
Although the size of these crystallin aggregates is influenced 
by many factors such as temperature (Tompson and Augusteyn, 
1983), ionic strength and pH (Van den Octelaar, et al., 1988), 
recent research has found that the crystallin terminal extensions 
play major roles in forming the aggregates. In their recent *H 
NMR studies, Carver et al. (1992, 1993) and Cooper et al. (1993) 
have confirmed that p-crystallin subunits have both C-terminal 
and N-terminal extensions while the four acidic p -crysta llin  
subunits have N-terminal extensions only. They also confirmed 
that monomeric Y_crysIa^in does not have any significant C- or N-
10
terminal extensions which suggests that the C- and N-terminal 
extensions may play major roles in forming a - and p-crystallin  
aggregates (Carver and Truscott, unpublished results).
Until now, the function of these terminal extensions has not 
been very clear, however, it has been speculated that they act as 
attachment sites for oligomer formation or for binding to other 
cellular components.
These crystallin aggregates are one level of the lens protein 
arrangement, and this arrangement is capable of maintaining lens 
transparency. In this sense, the terminal extensions of the 
crystallins have great importance. It has been confirmed that the 
terminal extensions have great conformational flexibility and 
move independently of each other in the aggregates (Carver, et al., 
1992, 1993). This property makes the terminal extensions easier 
to be digested and cleaved by proteases (which exist in the eye) 
than the bulk of crystallins. In their proteolytic studies, Yoshida et 
al. (1986) have found that a variety of proteases can cleave the C- 
terminal of aA crystallin. Some age-related degradation of the C- 
terminal extensions of aA and pH crystallins have also been found 
by recent electrospray mass spectrometry analysis (Kilby, 
Truscott and Sheil, unpublished result).
a-Crystallin is normally present as an 800 kDa multimer 
containing aA  and aB subunits. In their NMR spectroscopy 
research, Carver et al. (1992) have confirmed that the last eight 
amino acids in the aA C-terminal extension (K-P-S-S-A-P-S-S 
166-173) and the last ten amino acids in the aB C-terminal 
extension (K-P-A-V-T-A-A-P-K-K 166-175) have great
11
conformational flexibility and move independently of each other 
in the bovine lens a-crystallin aggregates.
Because the crystallins play an important role in the lens, 
revelation of their metabolism can lead to more understanding 
about the lens and its diseases. The metabolism of the lens 
crystallins may be divided into two aspects, their synthesis and 
breakdown. Synthesis of lens crystallins is continuous throughout 
life and new cells which are formed in the epithelial layer, 
elongate and add to the old cells peripherally. The amino acids 
required for the synthesis of crystallins are transported into the 
lens from the aqueous humour. As a result of this new cell 
formation, the lens grows bigger, thicker and heaver with ageing 
(Harding and Crabbe, 1984). The study of lens crystallin 
breakdown has concentrated on the effects of proteolytic 
enzymes. In the normal breakdown pathway the lens crystallins 
are first digested by endopeptidases, the resulting peptides are 
then eliminated by stepwise degradation by peptidases. Both 
endopeptidases and peptidases have been separated from and 
identified in human and bovine lenses (van Heyningen and Wale, 
1963; Harding and Crabbe, 1984; Taylor et al., 1984). However, 
overall the rate of crystallin breakdown is very small.
This work was aimed at using gel filtration techniques to 
purify pB2 and aA crystallins from foetal and ageing bovine lens. 
Then a tryptic digestion method was used to cleave the C-terminal 
extensions of PB2 and aA  crystallins. Simultaneously, the 
synthetic model polypeptides of C-terminal extensions of pB2 and 
aA crystallins were treated at the same way. HPLC was used to 
separate and purify the C-terminal residues of pB2 and a A
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crystallins according to the retention time obtained from model C- 
terminal polypeptides. Capillary electrophoresis and electrospray 
mass spectrometry are used to identify that there was a serine 
lost from the C-terminal of the both crystallins with ageing. The 
purpose of this work was to confirm that C-terminal serine was 
lost, which suggests that there are carboxypeptidase A-like 
enzymes in the bovine lens which digest the C-terminal residue of 
the pB2 and ocA crystallins during the ageing process.
1.6. C apillary  Electrophoresis
Fig. 4. Schematic diagram of a capillary electrophoresis system.
Figure 4. shows a schematic diagram of a capillary
electrophoresis instrument which consists of a fused silica
capillary column, two electrolyte buffer reservoirs, a detector (UV 
absorbance is the most common) with data integrator and a high- 
voltage (30 kV) power supply. The fused silica capillary columns 
range from 10 to 100 cm in length, with inner diameters of 20 to
200 pm and the detector is placed near the end of the capillary
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column. The inside wall of the fused silica capillary column is 
negatively charged over a wide pH range in aqueous solution, 
because its surface is covered by silanol groups. When a voltage is 
applied, there is a nett flow of the buffer, referred to as the 
electroosmotic flow, caused by the electrical double layer formed 
at the wall-electrolyte interface. When the flow is towards the 
cathode (inlet positive) any components with a positive charge 
emerge early because both the electrophoretic motion of the ion 
and the electroosmotic flow of the buffer are in the same 
direction. Negatively charged components also migrate toward the 
cathode, provided their electrophoretic mobility is less than the 
electroosmotic flow, but with a much lower rate. The 
electroosmotic flow and mobilities are governed by the nature and 
concentration of the buffer, the applied voltage and the length of 
capillary. Hence these parameters can be varied to control the 
component to be separation.
Thus, this work relates to determining the optimum CE 
operating conditions for short peptides (< 3000 Da) separation.
Capillary electrophoresis (CE) was first described by 
Virtanen (1974), but it did not show a significant growth in 
popularity as an analytical technique until Jorgenson and Lukács 
did the pivotal work in early 1980s with narrow bore capillaries 
(1981). Commercial CE systems became available in 1990 and due 
to its simplicity, high resolution, ease of quantification and ability 
to perform rapid automated analysis of multiple samples, CE has 
been widely applied in the field of biochemistry and molecular 
biology, [see for example recent reviews by Gordon et al. (1988);
14
Ewing et al. (1989), Drossman, H. et al. (1990), Kuhr, W. G. and 
Moning, C. A. (1992) and Xu,Y. (1993)].
1.7. E lectrospray Mass Spectrom etry
Electrospray Mass Spectrometry (EMS) is a recently- 
developed technique which has enabled accurate molecular 
weight determination of proteins and other biomolecules up to 
150kDa. EMS is becoming a vital tool in the biological and 
biochemical research areas [see for example the recent reviews by 
Today’s Life Science (1992) and Smith et al. (1990)].
With electrospray mass spectrometry the sample solution is 
introduced into the atmospheric pressure ion source of the 
spectrometer through a silica or stainless steel capillary tube. As a 
consequence of the strong electric field between the end of the 
capillary and the counter electrode, the sample solution emerging 
from the capillary is dispersed into an aerosol of highly charged 
droplets -  the electrospray. These droplets, assisted by a flow of 
warm gas flowing through the source, diminish in size by 
evaporation until a point is reached where multi-charged ions of 
individual protein molecules, free of solvent, are released. Some of 
these ions pass through a small hole (the sampling orifice) into a 
pumped intermediate vacuum region at about 1 mbar pressure 
and then through a second small hole (the skimmer) into the 
quadrupole analyser, where their mass-to-charge ratios are 
measured.
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With proteins, a multiply-charged envelope is normally 
produced, thus enabling determination of molecular weights with 
accuracies of the order of 0.1%.
1.8. Aims of this work
Thus this thesis attempts to address two important 
problems for lens research. Firstly, the synthesis of 3- 
hydroxykynurenine glucoside was tried by three different 
methods, with the goal of finding a cost effective method of 
obtaining this compound for the further study of its role in the 
lens. Secondly, the proteins aA crystallin and pB2 crystallin from 
bovine lenses were studied in aged and foetal lenses in an attempt 
to confirm an age-related loss of serine from the C-terminal 
extension of these proteins, which in turn may be an indicator of 
enzymatic activity in the lens.
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CHEMICAL SYNTHESIS OF 3-HYDROXYKYNURENINE
GLUCOSIDE: METHOD ONE
Three methods were tried for the synthesis of 3-hydroxy- 
kynurenine glucoside.
The starting materials for synthesis method one were 3- 
hydroxykynurenine and methyl a-D-pyranoside. As there were 
several reactive groups on both starting materials, it was 
necessary to block the sites at which the reactions were not 
desired in order to reduce the formation of side products.
The strategy for synthesis of 3-hydroxykynurenine 
glucoside according to this method is shown in Scheme 2.
2.1. Blocking reactive sites in 3-hydroxykynurenine
Since 3-hydroxykynurenine is a phenol, the aim of this 
synthesis was for the glucose to be attached to the hydroxy group. 
However, 3-hydroxykynurenine also has an amino acid group 
which is potentially very reactive. Thus, in order to get a high 
yield, methylation was chosen to block the -COOH group of 3- 
hydroxykynurenine. This was performed by adding 3- 
hydroxykynurenine to 10% thionyl chloride in methanol or 10% 
hydrochloric acid moisture (by weight) acidified methanol. After
18
the reaction was complete, a new UV reactive spot appeared on 
the TLC, with a slightly greater Rf value than the starting 
material, which was identified as 3-hydroxykynurenine methyl 
ester.
The amino group of 3-hydroxykynurenine was blocked 
using 2 equivalents of methyl trifluoroacetate and 2 equivalents 
of triethylamine in methanol to generate the N-trifluoroacetic acid 
(TFA) methyl ester. The mixture was then stirred at room 
temperature until the 3-hydroxykynurenine methyl ester spot 
disappeared on TLC. Purification was performed by column 
chromatography on silica. The N-TFA-3-hydroxykynurenine 
methyl ester was obtained in 60% yield. The negative and the 
positive ESI mass spectra gave the molecular weight data at 333 
and 335, for [M-H]~ and [M+H]+ ions respectively, consistent with 
the N-TFA-3-hydroxykynurenine methyl ester molecular weight 
of 334. The NMR spectrum showed three aromatic resonances 
at 57.51, 7.20 and 5 6.77 as three doublets. A singlet at 53.71 also 
indicated that there were three methyl protons. All of these 
analytical data indicate that these two steps of the synthesis were 
successful.
There is another amino group on the aromatic ring at 
position 2. The reactivity of this group is reduced due to the effect 
of steric hindrance, hence, blocking is not required.
2.2. Blocking hydroxyl groups on methyl a - D - p y r a n o s i d e
Methyl a-D-glucopyranoside was used as a starting material. 
In this two step reaction, based on the method of Glaudemans et
19
al. (1972), the hydroxy groups were first blocked by benzyl 
groups and secondly the methyl group on C-l was converted to a 
hydroxy group.
The reaction was performed by dissolving methyl a - D-  
glucopyranoside and powdered potassium hydroxide in dry 
dioxan. Benzyl chloride was added to block the four hydroxy 
groups of the methyl a-D-glucopyranoside. At the end of this 
reaction, the crude product, methyl tetrabenzylglucose, was 
obtained as a syrup in 95% yield.
The methoxy group of methyl tetrabenzylglucose was 
converted to a hydroxy group by dissolving the syrup in boiling 
glacial acetic acid and diluting with boiling 2M sulphuric acid 
twice. The 2M sulphuric acid must be kept boiling when pouring it 
into the boiling mixture, otherwise a syrup will form which is 
difficult to redissolve. After cooling, the mixture was poured into 
water. The crystals which formed in the water were recrystallized 
from methanol to obtain tetrabenzylglucose as white crystals with 
70% yield. The NMR spectrum and the melting point at 142°C 
(literature 143°C) were consistent with the structure.
2.3. Coupling of N-TFA-3-hydroxykynurenine methyl  
ester to 2,3,4,6-tetra-o - b e n z y  1 - g l u c o p y  ran ose  ( t e t r a ­
b enzy lg lucose )
The coupling reaction employed a fusion method of 
Tsutsumi and Ishido (1981) in which tetrabenzylglucose is first 
fused with dicyclohexylcarbodiimide (DCC) and copper (I) chloride
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is involved as a catalyst. In this stage the tetrabenzylglucose was 
converted to O -(tetrabenzylglucose) pseudourea. Thus, based on 
the principle that pseudourea formation will make the compound 
more nucleofugal, the only free hydroxyl group on the anomeric 
carbon atom (the others were blocked by benzyl groups) becomes 
very reactive. After phenol was added in the second stage, the 
coupling should then involve in a simple SN2 reaction. In the 
model experiments using this reaction with forty-nine phenols 
(Tsutsumi and Ishido, 1981), the highest yield was 93%.
For this work, it was necessary to slightly alter this fusion 
method as the 3-hydroxykynurenine is a phenol which is not 
stable at high temperature. In the presence of Cu(I), chloroform 
was used as solvent, so the coupling reaction could be carried out 
at room temperature. At the end of the first step, after the O- 
(tetrabenzylglucose) pseudourea was formed, the catalyst 
(copper(I) cloride) was washed out using 0.5 M aqueous ammonia 
solution, followed by water.
As the coupling reaction was carried out at a low 
temperature, the mixture was kept stirring for 4 days to 
maximise the yield (see general procedure 4.1.3 for the details). 
The final product was a yellow-white solid obtained with 70% 
yield.
2.4. Débenzylation (deprotection of tetrabenzylglucose)
The deprotection of N-TFA-3-hydroxykynurenine methyl 
ester was performed in dry glacial acetic acid with 10% palladium
21
on activated carbon as a catalyst and under a hydrogen 
atmosphere.
The NMR data showed that the débenzylation was 
unsuccessful. There are two possible reasons which may have 
caused the failure of the reaction. First, the TFA group on the 
starting meterial, N-TFA-3-hydroxykynurenine, may have 
poisoned the catalyst. Alternatively, after débenzylation was 
complete, the glucoside may have hydrolysed, being split into N- 
TFA-3-hydroxykynurenine methyl ester and glucose immediately 
by the acetic acid if the acetic acid was not absolutely dry.
The failure of the débenzylation step prevented any further 
progress with this method.
o




CHEMICAL SYNTHESIS OF 3-HYDROXYKYNURENINE
GLUCOSIDE: METHOD TWO
The rationale behind this method of synthesis was to use 
basic, readily available starting materials to enable large amounts 
of 3-hydroxykynurenine glucoside to be prepared. The starting 
materials involved in this synthesis were 3-hydroxyacetophenone 
and D-(+)-glucose.
The synthetic strategy is shown in scheme 3.
3.1 Preparation of 2-nitro-3-hydroxyacetophenone from 
3 - h y d r o x y a c e t o p h e n o n e
This reaction employed a nitration method which was 
carried out by treating 3-hydroxyacetophenone with acetic 
anhydride and cupric nitrate trihydrate in dry glacial acetic acid 
at low temperature (Butenandt et al., 1957). The nitro group 
added to the C2, C4 and C6 positions of the aromatic ring, so this 
reaction gives a mixture which contains three nitro-isomers. 
Fractional recrystallisation from benzene was used to separate the 
three nitro-isomers, which was a key step of this reaction in 
determining the overall yield, (see general procedure 4.2.1 for the 
details). The required isomer was a yellow solid which was
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obtained in 8.1% yield. This isomer was identified by the NMR 
spectrum showing three doublets of doublets resonating at 57.68­
7.50, 57.26-7.14, 56.87-6.77 for the three aromatic protons, and a 
singlet resonating at 52.51 for the three methyl protons. The other 
two nitro-isomers had NMR chemical shifts clearly different from 
the desired compound. The MS spectrum with 182 (M+) and the 
melting point at 135°C (literature 138°C) confirmed the synthesis 
of the required compound.
3 .2 .  P r e p a r a t i o n  o f  2 , 3 , 4 , 6 - t e t r a a c e t y l - a  - g 1 u c o ■ 
pyranosy l  bromide (acetobrom oglucose)
Acetobromoglucose was prepared by the method from 
Vogel’s Textbook of Practical Organic Chemistry (Furniss, et al., 
1989). This method used D-(+)-glucose as the starting material. In 
the reaction, with acetic anhydride as solvent, red phosphorus and 
bromine as reagents, and perchloric acid as a catalyst, the 2,3,4,6- 
hydroxy groups were blocked by acetyl groups and the 1-hydroxy 
group was substituted by a bromine. The crude product obtained 
was recrystallised from ether-hexane giving acetobromoglucose as 
white crystals. The melting point of 87°C (literature 88-89°C), and 
the Iff NMR spectrum which shows the Cl proton as a doublet at 
56.63 and 56.58, and the four acetyl group protons as three 
singlets at 52.09, 2.04 and 2.01, confirmed this compound was the 
desired product.
3 .3 .  C o u p l in g  2 - n i t r o - 3 - h y d r o x y a c e t o p h e n o n e  with  
a c e t o b r o m o g l u c o s e
In this method glucose was attached to the 2-nitro-3- 
hydroxyacetophenone via a coupling reaction with aceto­
bromoglucose.
Theoretically, this coupling step could be easily affected in 
basic conditions, so after dissolving 2-nitro-3-hydroxyaceto- 
phenone in dry acetone, potassium carbonate was added. The 
acetobromoglucose was added to the mixture dropwise because it 
was not very stable in base. After reaction, the crude product was 
recrystallized from ether to give the pure 2-nitro-3- 
hydroxyacetophenone acetoglucoside as a white solid obtained in 
80% yield. The NMR spectrum showed four acetate proton groups 
at 82.01, 2.02, 2.07, 2.11 and three methyl protons as a singlet at 
82.56. At 83.89 and 5.21 there were five sugar protons and there 
were three aromatic protons with chemical shifts of 87.53. The 
NMR data and the melting point of 168°C confirmed the identity 
of this product.
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3 .4 .  B r o m in a t io n  of  2 -n i tr o -3 -h y d r o x y a c e to p h e n o n e  
t e t r a a c e t o g l u c o s i d e
This reaction used dioxan dibromide as the brominating 
reagent which was prepared by a simple synthesis modified from 
the method of Pasaribuet and William, (1973).
The dioxane dibromide was prepared by dissolving dioxane 
in hexane and adding 1 equivalent of bromine over 10 min. The
26
orange crystals which precipitated from solution were dioxan 
dibromide. This brominating reagent should be used immediately 
or stored at the temperature below -20°C as it is both hydroscopic 
and volatile.
The brominating reaction was performed by adding dioxane 
dibrom ide to 2-nitro-3-hydroxy-acetophenone tetraaceto- 
glucoside dichloromethane solution. Recrystallization from ethanol 
gave the a - b r o m o - 2 - n i t r o - 3 - h y d r o x y a c e t o p h e n o n e  
tetraacetoglucoside as a white solid with a 66% yield. In this 
reaction the key aspects are the amount of dioxane dibromide 
added and the reaction time. If too much dioxane dibromide and 
/or too long a reaction time is used, dibromination would take 
place on the a  carbon. The lH  NMR data showed three aromatic 
protons at 87.56 as a singlet and the four acetyl group protons 
were at 82.03, 2.04, 2.09 and 2.13. After bromination the chemical 
shift of the protons on the a carbon changed from 82.56 to 4.30. 
The 1 3 c  NMR spectrum confirmed that this synthesis was 
successful.
3.5 Coupling o c - b r o m o - 2 - n i t r o - 3 - h y d r o x y a c e t o p h e n o n e  
te traacetoglucoside  with ethyl nitroacetate
This reaction used ethyl nitroacetate as a reagent to 
introduce the nitroacetate group to the a - b r omo - 2 - n i t r o - 3 -  
hydroxyacetophenone tetraacetoglucoside and NaH was used to 
form the carbanion. After reaction the DMF was removed under 
vacuum and the residue was purified on a preparative TLC plate. 
Three main spots were collected for NMR analysis.
The NMR spectrum of the second spot showed that the 
coupling reaction worked but in a very low yield. Thus more work 
is required to optimize the reaction conditions for this step but 
this could not be accomplished within the time frame of this 








CHEMICAL SYNTHESIS OF 3-HYDROXYKYNURENINE 
GLUCOSIDE: METHOD THREE
This final method combined the most promising aspects of 
the previous two unsuccessful syntheses.
In this synthesis, 3-hydroxykynurenine and a-D-(+)-glucose 
were chosen as the starting materials, but the glucose was blocked 
in the same manner as was the acetobromoglucose in the method 
two. This is less desirable than strategy 2 since 3- 
hydroxykynurenine is a much more expensive starting material 
than 3-hydroxyacetophenone.
The proposed synthetic strategy for synthesis 3 is shown in 
Scheme 4.
4.1. Synthesis of 3-hydroxykynurenine glucoside
In this two step synthetic method, 3-hydroxykynurenine 
was dissolved in a sodium carbonate/sodium hydrogen carbonate 
buffer (pH 10.5). The phenol group of 3-hydroxykynurenine was 
converted to a phenoxide ion under these basic conditions in 
order to make it reactive. This change ensured the following 
coupling reaction proceeded more easily. The amino acid groups of 
3-hydroxykynurenine also became more reactive, this contributes
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to the formation of undesirable side products. After the phenoxide 
ion formed, acetobromoglucose in acetone was added dropwise 
over four hours. This extended period of adding 
acetobromoglucose was required because the acetobromoglucose 
was unstable under the basic conditions. Another function of the 
sodium carbonate/sodium hydrogen carbonate buffer was to 
neutralize the HBr which was formed in the coupling reaction and 
to maintain the pH of the reaction mixture at 10.5.
After the reaction had finished, three new UV-reactive spots 
appeared on the TLC plate. One of these newly formed spots had a 
bright-blue fluorescence, possibly due to the 3-hydroxy group 
being blocked (van Heyningen, 1973a). The electrospray MS 
analysis showed the molecular weight to be 554 which 
corresponds to the molecular weight of acetylated 3- 
hydroxykynurenine glucoside.
Thus, given that TLC and electrospray MS analyses showed 
that the coupling reaction had worked, sodium hydroxide was 
used to de-acetylate the coupled product to obtain the 3- 
hydroxykynurenine glucoside.
4.2. Purification of 3-hydroxykynurenine glucoside
After de-acetylation, the solvent was removed from the 
reaction mixture under vacuum. The first separation was 
performed using a C l8 cartridge. The aim of this step was to 
separate the water soluble 3-hydroxykynurenine glucoside from 
undesired compounds which were water insoluble and also to
31
desalt the sam ple. The fractions which eluted by water from the 
C l 8 cartridge were collected and dried. They were redissolved in 
the H PLC buffer and in jec ted  to the HPLC for the second 
separation (see general procedure 7.3 for details).
The resulting HPLC chrom atogram  is shown in Fig.5
Fig. 5. HPLC profile of the purification of 3-hydroxykynurenine
glucoside. The numbers above the peaks are retention time in minutes. The compounds 
were shown to be 3-hydroxykynurenine (14.48 min), 3-hydroxykynurenine a- 
glucoside (16.86 min) and 3-hydroxykynurenine p-glucoside (17.5 min). This HPLC 
separation method was adopted from Wood and Truscott (1993).
T he 3 -h y d ro x y k y n u ren in e  g lucoside peak was co llec ted  
fo llow ing HPLC separation and dried under vacuum. In order to
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test the product, a small portion of synthetic '3- 
hydroxykynurenine glucoside' was taken and hydrolysed with 0- 
glucosidase. The hydrolysed 3-hydroxykynurenine glucoside 
solution was then reinjected onto HPLC. The HPLC chromatogram 
showed that a 3-hydroxykynurenine peak had appeared while 
the ’glucoside' peak disappeared. The hydrolysed 3- 
hydroxykynurenine glucoside also separated by TLC with Butanol: 
Acetic acid : Water (4:2:1) as the developing solvent, and staining 
with silver nitrate-sodium hydroxide. The stained glucose 
appeared with dark brown colour and an Rf value of 0.38. The 
third test was performed by mixing the synthetic 3- 
hydroxykynurenine glucoside with the 3-hydroxykynurenine 
glucoside extracted from human lens (Wood and Truscott, 1993), 
and reinjecting the mixture onto HPLC. The HPLC chromatogram 
showed that the 3-hydroxykynurenine P-glucoside peak had not 
broadened and the retention time had not changed.
Further purification and desalting was performed by the 
way of chromatography employing a Sephadex G10 column. The 
sample was eluted with water at a flow rate of 5ml/hr and 1.5ml 
each fractions were collected. The UV absorbances of the fractions 
were measured at 229nm and 365nm.
The obtained LC profiles are shown in Fig. 6.
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Fig. 6. The Sephadex column chromatography profile of purification and 
desalting synthetic 3-hydroxykynurenine glucoside sample.
The fractions from 20 to 29 were combined and dried under 
vacuum to give the pure 3-hydroxykynurenine glucoside.
The lH  NMR spectrum (D2O) showed three aromatic protons 
at the chemical shifts of 57.48, 7.16, and 6.61. The a carbon proton 
occurs at 53.63, and (3 carbon protons at the chemical shifts of 
53.61, 3.36 as a doublets of doublets. The C l sugar proton is a 
doublet at 5 4.9, and the other sugar protons are a multiplet at 
53.46. The C'6 sugar protons are a doublet at 53.78.
The UV spectrum showed the synthesised compound had 
three absorption maxima at 365, 263 and 227nm which match the 
published data for 3-hydroxykynurenine glucoside. The UV 
absorption of 3-hydroxykynurenine is at 368, 267 and 368nm 
(Bando, et al 1981).
34
Fig. 7. UV-Spectra of 3-hydroxykynurenine glucoside (1) and 3- 
hydroxykynurenine (2).
T he e lec tro sp ray  MS spectrum  show ed a p ro tonated  
m olecu lar ion at 386 consistent with the 3-hydroxykynurenine 
glucoside molecular weight of 385.
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The three dim ensional fluorescence spectrum  showed the 
sy n th esised  3 -h y d ro x y k y n u ren in e  g lucoside  has a exc ita tion  
m axim um  (Ex) at 325nm and the em ission maximum (Em) at 







Fig.8. The three dimensional fluorescence spectrum of 3-hydroxykynurenine 
glucoside.
Thus, the analytical data above proves that this third
m ethod for syn thesis of 3 -hydroxykynuren ine g lucoside was 
successfu l.
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Amino acid sequence of a A-crystallin from bovine lens
6 1 1 16 21
1 M D I A I Q H P W F K R T L G P F  YP S R L F DQ
26 F F G E G L F E Y D L L P F L S S TI  S P Y Y R Q
5 1 S L F L T V L D S G R S E  VR S DRDK F V I F L
76 D V K H F S P E D L T VK VQ E D F V E I H G K H
101 N E R Q D D H G Y I S R E F H RR YRL P S N V D
126 QS AL S C S L S  A D G M L T F S G P K I P S G  V
151 D A G H S A R A I P V S R E E KP S S A P S S
Number of residues=173
Amino acid sequences of synthetic poly-peptide
S R E E K P S S A P S S
SCHEME. 5. Amino acid sequences of bovine lens a A - 
crystallin. In this experiment, trypsin was used to cleave the C- 
terminal extensions from both a A-crystallin and the synthetic 
polypeptide. Carboxypeptidase A was used to cleave serine from 
the synthetic polypeptide to generate the corresponding C- 
terminal extension of aA-crystallin minus serine.
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Amino acid sequence of bovine lens PB2 - c r y s ta l l
6 1 1 16 21
1 A S D H Q T Q A G K P Q P L N P K 111 F E Q E N
26 F Q G H S H E L N G P C P N L K E T G V E K A G S
51 V L  V Q  A GP W VG Y E Q A N CKGEQ F V F E K
76 GE Y P R W D  S WT S S R R T D S L S S L R P I K
101 V D S Q E H K I T L Y E N P N F T G K K ME V I D
126 D D  V P S F H A H G Y Q E K V SS  V R V Q S G T W
151 V G Y Q Y P G Y R G LQ Y L L E K G D Y K D S G D
176 F G A P Q PQ V Q S V R R I R DMQWH QRG AF
201 HP S S
Number of residues=204
Amino acid sequences of synthetic poly-peptide 
M Q W H Q R G A F H P S  S
SCHEME. 6. Amino acid sequences of bovine lens pB2 
crystallin. In this experiment, trypsin was used to cleave the C- 
terminal extensions from both pB2-crystallin and the synthetic 
polypeptide. Carboxypeptidase A was used to cleave serine from 
the synthetic polypeptide to generate the corresponding C- 
terminal extension of PB 2-crystallin minus serine.
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A S D H Q T Q A G K P Q P L
N P K I I I F E Q E N F Q G H
S H E L N G P C P N L K E T
G V E K A G S V L V Q A G P
W V G Y E Q A N C K G E Q
F V F E K G E Y P R W D S W
T S S R R T D S L S S L R P I K
V D S Q E H K I T L Y E N P
N F T G K K M E V I D D D
V P S F H A H G Y Q E K V S
V R V Q S G T W V G Y Q Y
P G Y R G L Q Y L L E K G D
Y K D S G D F G A P Q P Q V
Q S V R R I R D MQ WH Q R
G A F H P S S
PB 21-204
Carboxypeptidase A­
like proteinase digest 
the pB2-crystallin of the 
bovine lens through out 
the life. A serine is 
cleaved from the 
C-terminal extension
A S D H Q T Q A G K P Q P L
N P K I I I F E Q E N F Q G H
S H E L N G P C P N L K E T
G V E K A G S V L V Q A G P
WV G Y E Q A N C K G E Q
F V F E K G E Y P R W D S W
T S S R R T D S L S S L R P I K
V D S Q E H K I T L Y E N P
N F T G K K M E V I D D D
V P S F H A H G Y Q E K V S
V R V Q S G T W V G Y Q Y
P G Y R G L Q Y L L E K G D
Y K D S G D F G A P Q P Q V




G AF HP S S ,  G A F H P S  and PB2i„i97
H
Confirmation of the C-terminal serine 
loss of the bovine lens pB2crystallin
SCHEME. 7. General diagram of the method of confirmation 
of the C-terminal serine loss of pB2-crystallin
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CHAPTER 5
SEPARATION AND ANALYSIS OF BOVINE LENS
CRYSTALLINS
As mentioned in chapter one, the lens crystallins are
digested to some extent by a range of enzymes throughout the
life of the lens. The N- and C-terminal extensions of the
crystallins are relatively independent from the globular domains, 
so the residues on the terminal extensions may be more readily 
digested by enzymes. In this work, based on the discovery of 
proteins accompanied by apparent serine loss species by
electrospray mass spectrometry, we attempted to use the method 
shown in scheme 7 to confirm this serine loss is from the C- 
terminal extensions of the aA and (3B2 crystallins from bovine 
lens.
Firstly, digestion with the enzyme trypsin (which specially 
cleaves proteins or peptides at arginine and lysine residues) was 
used to cleave the C-terminal extensions of the a A and (3B 2 
crystallins. The resulting C-terminal peptides were separated and 
purified by High Performance Liquid Chromatography (HPLC). At 
the same time, a synthetic C-terminal extension model 
polypeptide for the normal sequence and a serine loss C-terminal 
extension model polypeptide (serine was cleaved by 
carboxypeptidase A from the normal C-terminal extension model
40
polypeptide) were treated in the same way, to get the required 
HPLC retention times of the trypsin-cleaved C-terminal peptides. 
Then it was aimed to use the high resolution capability of the 
capillary electrophoresis (CE), and the accurate molecular weights 
determined by electrospray mass spectrometry as the methods to 
analysis of the HPLC fraction to confirm that there is a serine loss 
from the C-terminal extension of aA and (3B2 lens crystallins.
5.1. Separation of bovine lens crystallins
This crystallin separation method is modified from that 
published by Kleiman et al. (1988).
Nine-year-old bovine eyes were obtained from a local 
abattoir and the foetal bovine lens protein was obtained from Dr. 
R. C. Augusteyn, National Institute of Vision Research, Melbourne. 
The age of the animal was calculated from the weight of the lens 
using the following formula:
W=IA02 log(f + 9.3) -0.221
where w is grams and t is number of months (Hockwin, 1987).
The lenses were removed from the eyes and the crystallins 
were extracted in a 50mM Tris/HCl (pH=7.5), ImM EDTA, O.lmM 
phenylmethylsulfonyl fluoride, O.lmM 1,4-dithiothreitol and
0.02% sodium azide buffer (2ml/gram lens) using a glass 
homogenizer. The insoluble material was removed by centrifuging 
at 15000 G for 20 minutes at room temperature. The supernatant 
containing the water-soluble crystallins was loaded on a
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Sepharose CL-6B column which had been equilibrated in 50mM 
Tris/HCl (pH=6.8) buffer. The same buffer was used to separate 
the crystallins with the flow rate of 16ml/hr and 3.75ml fractions 
were collected. Fractions 39 to 48 were collected as a-crystallins, 
fractions 50 to 56 were collected as (3 high (pH) crystallin, 57 to 60 
were collected as p low 1 (pLl) crystallin and 61 to 67 were 
collected as p low 2 (PL2) crystallin. These p fractions represent 
different molecular fractions of the aggregated p subunits. The gel 
filtration chromatography profile is shown in figure 9. The 
remaining crystallin class, i.e. y crystallins, were not of interest for 
this work.
Fig. 9. The profile of the 9-year-old bovine lens crystallins 
separation
The separated pH and PL2 crystallin fractions were 
concentrated on a stirred ultrafiltration cell and completely 
dialysed against Milli Q water before lyophilisation in a freeze 
drier. The dried crystallin samples were stored at 4°C, prior to 
electrospray mass spectrometry analysis and tryptic digestion.
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a-Crystallin fractions were concentrated on a stirred 
ultrafiltration cell and reloaded on a Sephadex G-75 column 
which was equilibrated with 0.1M glycine at pH 2.5. The 
individual a  A and ocB subunits were eluted by the same buffer 
with the flow rate at 13ml/hour and 6.5 ml fractions were 
collected. Fractions 20 to 31 were pooled as a A and fractions 36 to 
45 were gathered as aB crystallins. The aA and ocB collections 
were concentrated, dialysed and freeze dried in the same way as 
p -crystallins and were stored at 4°C.
Fract io  ns
Fig. 10. The elution profile for separation of total a- 
crystallin into subunits.
The purity of the samples was checked by electrospray mass 
spectrometry using the method described in general procedures 
(chapter 7). The mass spectra of p High and a fractions are shown 
in Fig. 11 and 12 respectively. In these spectra a-crystallins give 
molecular weights of aA 19834 Da; phosphorylated aA 19914 Da; 
aB 20082 Da, and phosphorylated aB at 20163 Da. In all of the pH,
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PL1 and pL2-crystallins fractions studied there is a large PB2 peak 
at molecular weight 23210 Da, which is consistent with earlier 
work showing this to be the major component in each fraction 
(Harding, 1992). The molecular weight data of the a and the major 
components of the p fractions correspond exactly to the 
theoretical molecular weights derived from the known sequences 
of these crystallins with the exception of PB3 which is currently 
being investigated in more detail (Kilby, Sheil and Truscott, 
unpublished work). The aA and pH crystallin mass spectra also 
gives the first evidence that there is a serine loss from these two 
crystallins since the spectra of the a  A and pH fractions showed 
peaks at 19747 Da and 23122 Da consistent with loss of serine (87 
Da) from aA and PB2 respectively. These peaks were absent from 
the electrospray mass spectra of the foetal lens proteins which is 
a strong indication of an age-related change. Emmons and 
Takemoto (1992) have also recently demonstrated, by 
combination of tryptic digest method and mass spectral analysis, 
that the loss from a  A is indeed the C-terminal serine. Thus this 
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5.2. Preparation of the model experiment for the serine 
loss of (3B2 C-terminal extension
In order to collect the desired HPLC peaks which correspond 
to the trypsin cleaved C-terminal extension polypeptides and 
serine loss C-terminal extension polypeptides, a model sequence 
of pB2 crystallin C-terminal extension (M-Q-W-H-Q-R-Q-A-F-H-P- 
S-S 192-204) was custom-synthesised by Auspep Pty. Ltd. 
(Victoria, Australia). The purity of this polypeptide is HPLC grade, 
and it was synthesised by using a standard solid-phase synthetic 
methods. In this model peptide Metl92 and Gin 193 are not part 
of the flexible C-terminal extension of pB2 crystallin.
Carboxypeptidase A was used to cleave serine (204) from 
the model polypeptide. This was followed by tryptic digestion to 
split this peptide at Arg (197). The experimental procedure 
described in chapter 7 allowed for half the amount of peptide to 
be digested with carboxypeptidase A, with the aim of generating 
two desired polypeptides corresponding to the serine loss and 
normal C-terminal residues cleaved by trypsin from PB 2 
crystallin. The digested synthetic polypeptide solution was then 
injected onto the HPLC and separated under the conditions 
described in chapter 7. The HPLC peaks were collected, freeze 
dried and sent for amino acid analysis. CE analysis was also
carried out on these freeze dried polypeptide samples
The HPLC profiles for the synthetic peptide M-Q-W-H-Q-R- 
Q-A-F-H-P-S-S (192-204) before and after carboxypeptidase A 
and trypsin digestion are shown in Fig.s 13 and 14.
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Fig 14. The HPLC profile of the polypeptide after 
carboxypeptidase A and trypsin digestion.
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The amino acid analysis results are shown in Table 1.
Peak Area Peak Area
PI (serine loss) P2 (normal) P1/P2
Serine 6718016 13628377 0.49
Glycine 7718295 8660225 0.96
Histidine 1254988 1300167 0.94
Alanine 5657275 5994894 0.91
Phenylalanine 2394002 2646325 0.90
T able 1. A m in o  acid  analysis o f  H PLC  fraction o f  P I (C-term inal residue with  
serine lo s s )  and P 2  (norm al seq uence o f  C -term inal residu e). The num bers in the 
colum n are am ino acid peak area.
The HPLC profile showed that after the carboxypeptidase A 
and trypsin digestion, the synthetic polypeptide had been cut into 
three parts. The amino acid analysis results show that the HPLC 
peak 1 corresponds to the serine loss C-terminal peptide and the 
peak 2 is the normal sequence C-terminal peptide of the pB 2 
crystallin. The third peak is the N-terminal tryptic peptide from 
the synthetic peptide.
5.3. Preparation of the model experiment for the serine 
loss of ocA C-terminal extension
A model synthetic polypeptide for the sequence of the a A 
C-terminal extension (S-R-E-E-K-P-S-S-A-P-S-S 162-173) was 
also synthesised by Auspep Pty. Ltd. This peptide was treated
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with carboxypeptidase A and trypsin in the same way as the 
model peptide for (3B2 (see chapter 7). However, despite repeated 
attempts at the tryptic digestion (including digestion at 37°C 
overnight), it was not possible to cleave this peptide at Argl63, 
perhaps because of steric hindrance by the two adjacent glutamic 
acid residues.
Two alternative approaches using an arginine-specific 
protease from mouse submaxillary glands (Endoproteinase Arg- 
C), and staphylococcal protease (strain V8, EC 3.4.21.19) to try a 
cleave at the glutamic acid residues were also unsuccessful.
The failure to prepare the model tryptic digested a A C- 
terminal polypeptides (serine loss and normal sequence) made it 
difficult to continue with this aspect of the work since the tryptic 
digest a A crystallin resulted in a complex HPLC profile, in which 
it was not possible to decide which two peaks corresponded to the 
serine loss and normal sequence of C-terminal extensions.
5.4. Tryptic cleavage of the C-terminal extension of pB 2 
c r y s t a l l i n
With limited tryptic digestion, the C-terminal of pB 2 
crystallin can be removed at Argl97 resulting in a seven amino 
acid polypeptide (Berbers et al., 1984). The tryptic digestion of 
foetal and aging pB2 crystallin in this experiment used the 
method of Allen (1990). The detailed method for the C-terminal 
cleavage is described in 7.4.2.
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During the digestion, timed samples were taken and 
monitored by HPLC analysis. After examining the results, the 
optimal trypsin digestion time was determined to be 10 minutes. 
Within this time, rapid digestion preferentially occurred at Arg 
197 and no globular domain digestion was observed. This was 
also noted by Berbers et al. (1984)
5.5. pB2 C-terminal residues purification by HPLC
An optimized HPLC separation (see 7.5.3. for detail) was 
used for the purification of the tryptic pB2 C-terminal residues. 
Peaks with the same retention times as the model serine loss and 
normal C-terminal polypeptides were collected and freeze dried 
for CE and electrospray MS analysis.
The HPLC profiles of purification of C-terminal residues of
tryptic digest (3B2 crystallin
r




Fig 16. HPLC chromatogram from foetal bovine lens pB2 crystallin C-terminal 
residue.
These two HPLC chromatograms clearly show that the 
ageing pB2 crystallin has both serine loss (PI) and normal 
sequence (P2) C-terminal residues while the foetal pB2 crystallin 
has the normal sequence (P2) C-terminal residue only. Because 
there was some overlap of the peaks in figure 15, however, the 
fractions collected for CE and MS analysis were not completely
pure.
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5.6. Identification of the serine loss C-terminal residues 
and normal C-terminal residues of bovine lens pB 2 
crystallin by CE.
Figure 17 shows the capillary electrophoresis profile of the 
synthetic peptide model for pB2 crystallin which has been 
digested with both carboxypeptidase A and trypsin. This 
electrophoregram was obtained using a 0.1M tricine and 0.02M 
morpholine buffer (pH 8.1) and 10 kV applied voltage. In 
separate experiments described in chapter 7 these were 
determined to be the optimum conditions for the separation of 
the small peptides
In figure 17, the peak at 20.0 minutes is due to the G-A-F- 
H-P-S-S (198-204) peptide, the peak at 17.4 minutes from the 
corresponding serine loss peptide G-A-F-H-P-S (198-203), the M- 
Q-W-H-Q-R (192-197) peptide resulting from the tryptic 
digestion appears at the retention time 16.5 and there is a large 
peak due to the tryptic digestion buffer at 16.9 min. The very 
high resolution of the CE allows the two peaks of interested to be 







Fig. 17. CE profile of the trypsin digested synthetic PB2 C-terminal model 
polypeptides sample. The numbers above the peaks are retention times in minutes. The 
peptides were shown to be G-A-F-H-P-S-S (20.0), G-A-F-H-P-S (17.4) and M-Q- 
W-H-Q-R (16.5). The largest peak (16.9) is due to the NH4 HCO3 (tryptic digestion 
buffer).
Using the same CE conditions, the HPLC-purified pB2 C- 
terminal residues peaks (HPLC PI and P2) obtained from the 
tryptic digest of pB2 crystallin were also analysed by CE.





Fig 18. CE profile of serine loss C-terminal residue of PB 2 
crystallin (HPLC PI).
Fig 19. CE profile of normal sequence C-terminal residue of 
PB2 crystallin (HPLC P2).
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In Fig. 18 and Fig. 19, both the serine loss and normal 
sequence C-terminal residues appeared on the same 
electrophoregram at 16.8 and 19.7 min respectively. This is 
because these two peptides were not well separated by HPLC (see 
Fig. 15). However, in Fig. 18, which corresponding to the HPLC PI, 
the serine loss C-terminal residue is the most abundant species 
and in Fig 19, which corresponding to the HPLC P2 the normal 
sequence C-terminal residue is the most abundant.
5.7. Identification of the serine loss C-terminal residues 
and normal C-terminal residues of bovine lens pB 2 
crystallin by EMS.
The two HPLC fractions (PI and P2) obtained from 
purification of the trypsin digested pB2 crystallin were also 
analysed by electrospray mass spectroscopy using the conditions 
described in the general procedures (see 7.1.5 for detail).
The electrospray mass spectra are shown in Fig. 20 and 21 
for HPLC PI and P2 respectively. In these spectra, Fig. 20 gives a 
(M+H)+ peak at 615.2 Da and Fig. 21 gives a (M+H)+ peak at 702.3 
Da which corresponds to the trypsin cleaved serine loss (G-A-F-H- 
P-S MW=614.8) and normal sequence (G-A-F-H-P-S-S MW=701.9) 
C-terminal residues of PB2 crystallin respectively. As with the CE 
results, there is some small amounts of each of the peptides in 
both spectra but the most abundant species are consistent with 
the CE and HPLC results. The peak at 615 Da was not present in 
HPLC fraction collected from tryptic digested foetal 0B2 crystallin.
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5.8. Summary
Thus all the available evidence obtained from the combined 
MS, HPLC and CE data indicates that there is in fact an age-related 
serine loss from |3B2 crystallin, which in turn indicates that there 
is an unknown enzyme with activity like that of carboxypeptidase 
A in the bovine lens.
Fig. 20. Electrospray Mass Spectrum of trypsin cleaved 
serine loss C-terminal residue of bovine (3B2 crystallin
Fig. 21. Electrospray Mass Spectrum of trypsin cleaved 




Thus, in the first part of this project, of the three attempts to 
synthesis 3-hydroxykynurenine glucoside, only the third method 
involving directly coupling 3-hydroxykynurenine with 
acetobromoglucose successful, however, this method is limited for 
large scale synthesis because of the high cost of 3- 
hydroxykynurenine (A$ 900/per gram).
Therefore, in future work arising from this project, some of 
the information derived from the first method could be used to 
improve the yield of 3-hydroxykynurenine glucoside. For 
example, in method one, using blocked 3-hydroxykynurenine is a 
good design since in the third method, which used unblocked 3- 
hydroxykynurenine, during the coupling the acetobromoglucose 
could be attached to 3-hydroxykynurenine from at least three 
positions as evidenced by the presence of five by-products found 
when purifying the glucoside synthesised from the third method. 
This may be reduced if the blocking strategy were to be 
incorporated into the third method with a subsequent increase in 
yield.
Secondly, of the three synthetic methods, only method 2 has 
the possibility for synthesis of a large amount of 3- 
hydroxykynurenine glucoside, because it does not involve using 
3-hydroxykynurenine as a starting material, so, it would certainly
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be worthwhile to try and improve the yield of the coupling 
reaction which limited work on this method.
In the second phase of this project, the loss of serine from 
the C-terminus of PB2 crystallin was confirmed using a 
combination of HPLC, CE and MS (before and after tryptic 
digestion) analysis. No serine loss was observed at the C-terminal 
extension of foetal PB2 crystallin by HPLC and MS. Further, mass 
spectrometry results for a  A crystallin serve to confirm Emmons 
and Takemoto's (1992) observation of a similar age-related serine 
loss from this crystallin which also has the X-P-S-S sequence (K- 
P-S-S-A-P-S-S) at the C-terminal extension. The evidence of 
serine loss from the C-terminal extensions of the a  A and PB 2 
crystallin in aged bovine lens suggests that there is a 
carboxypeptidase A like proteinase present in the bovine lens 
that digests the bovine a A and PB2 crystallin C-terminal 
extensions gradually throughout life. The origin, structure and 
function of this proteinase is not clear, however, this C-terminal 
serine cleavage may affect lens function. For example, the C- 
terminal extensions of a  A and pB2 crystallin act as attachment 
sites for oligomers formation or for binding to other cellular 
components (Berbers, et al., 1984), and the cleavage of serine 
may prevent the formation of crystallin aggregates and hence 
lead to some loss of lens opacity.
Future work in this area could include extending this 
approach using mass spectrometry, HPLC and CE to look for futher 





7.1.1 Melting Points (m.p.)
Melting points were determined on a Reichert hot stage 
apparatus and are uncorrected.
7.1.2. Ultraviolet (UV) Spectra
Ultraviolet spectra were recorded on a Shimadzu UV- 
Visible Recording Spectrophotometer, Model UV-265.
7.1.3. l H  Nuclear Magnetic Resonance (NMR) Spectra
lH  NMR spectra were recorded on a JEOL FX 90Q Fourier 
Transform NMR Spectrometer operating at 90MHz, or a Varian 
Unity 400 NMR Spectrometer operating at 400MHz. The 
spectra were measured in CDCI3 unless otherwise stated, 
relative to tetramethylsilane (0.00 p.p.m.). Each signal was 
described in terms of chemical shift in p.p.m. from 
tetramethylsilane, multiplicity, intensity, coupling constant 
(Hz) and assignment in that order with the use of the following 
abbreviations: s, singlet; d, doublet; t, triplet; q, quartet; and m, 
multiplet.
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7 .1 .4 .  l ^ c  Nuclear Magnetic Resonance (NMR) Spectra
13C NMR spectra were recorded on a Varian Unity 400 
NMR Spectrometer operating at 100 MHz.
7.1.5 Mass Spectra (MS)
Fast atom bombardment mass spectra were recorded on 
a VG 12-12 mass spectrometer using a glycerol matrix. 
Electrospray mass spectra were recorded on a VG Quattro 
triple quadrupole mass spectrometer (VG Biotech, Altrincham, 
Chesire, England). The flow rate was 5ml/min and the source 
temperature was 65°C. Samples were dissolved in 50:50 
acetonitrile:water at a concentration of about 200 pmol/ml.
7.1.6. Thin Layer Chromatography (T.L.C.)
Thin layer chromatography was carried out on the 
5x7.5cm aluminium backed silica gel 60 plates F254 (MERCK).
7 #1 %7 # High perform ance Liquid Chromatography  
(HPLC)
(i) For purification of 3-hydroxykynurenine glucoside
High Performance Liquid Chromatography was carried 
out on an ICI HPLC System, employing an Activon GOLDPAK 
Cl8 column packed with SPHERISORB 5 ODS2 (25 x 0.46 cm). 
The isocratic mobile phase consisted of 20mM sodium acetate 
and 20mM acetic acid buffer, at pH4.5. The flow rate was 
0.6ml/min. Detection was carried out employing a Knauer 
variable wavelength monitor, set at 365nm. The
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chromatograms were recorded with a Shimadzu C-R6A data 
processor.
(ii) For Peptides
High Performance Liquid Chromatography was 
performed on a Waters HPLC system, employing a Waters 
Bondapak C-18 column. The mobile phase consisted of solvent 
A: water with 0.05%TFA (trifluoroacetic acid) , and solvent B: 
50% acetonitrile in water with 0.05%TFA. The solvent system 
employed consisted of gradient elution from 100% A to 59% B 
in 60 min. The flow rate was 0.8mL/min. Detection was 
carried out employing a Waters absorbance detector Model 
441, at either 229 or 280 nm.
7.1.8. Capillary Electrophoresis (CE)
Capillary electrophoresis was carried out on the ISCO 
model 3850 CE system, with a fused silica ISCO CE capillary 
column 50mm x 84cm. The length from injector to detector 
was 49 cm. The buffer system consisted of 0.1 M tricine and 
0.02 M morpholine, pH 8.1. The voltage and current used 
during the electrophoresis were 10 kV and 11mA respectively 
and results were recorded on a Shimadzu C-R6A Chromatopac 
data processor. The detector wavelength set at 210 nm.
7.1.9. Amino Acid Analysis (AAA)
Amino acid analysis was performed on a ICI AAA 
system, which uses a ICI 1150 HPLC pump and a 3 mm ODS-2 
Spherisorb HPLC column (150 x 4.6 mm ID). Two detectors 
were used on this system, a Knauer UV-Visible photometer
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with the wavelength set at 254nm and an ICI-1250 
programmable wavelength fluorescence detector set at 
ExX=262 nm, EmA.=314 nm. The binary gradient system 
employed 18% B to 99% B in 24 min. Buffer A: 20 mM 
ammonium dihydrogen-orthorphosphate(pH 7): methanol 
(85:15). Buffer B: 90% acetonitrile in water. The flow rate was 
l.Oml/min. An IBM computer was used as a recorder using the 
ICI DP 800 chromatography management system. The samples 
were prepared by using 9-fluorenylmethylchloro-formate (F- 
MOC) as the precolumn derivatisation reagent. (Haynes et al., 
1991).
7.1.10. General Methods
Evaporation of the organic solvent refers to removal the 
solvent on a Buchi rotavaporator (water aspirator pressure), 




tricine and morpholine were obtained from Sigma Chemical 
Company and used without further purification. Ethyl 
nitroacetate was obtained from Aldrich. Peptide A (M-Q-W-H- 
Q-R-G-A-F-H-P-S-S 192-204) and peptide C (S-R-E-E-K-P-S-S- 
A-P-S-S 162-173) were purchased from Auspep company.
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7.2. METHODS AND SYNTHESIS FOR THE COMPOUNDS OF 
SCHEME 1
7.2.1 Preparation of N-TFA-3-hydroxykynurenine methyl 
ester
3-Hydroxykynurenine (22.4mg, O.lmM) was added to 10ml 
of a stirred 10% thionyl chloride methanol solution. The solution 
was stirred at room temperature for 15 hr. TLC, with BAW 
(Butanol: Acetic acid : Water=4:2:l) as developing solvent, showed 
the appearance of a new UV active spot (Rf=0.6) and no starting 
material (3-hydroxykynurenine Rf=0.5). The solvent was 
evaporated and the residue was redissolved in 10 ml methanol. 
Triethylamine (20.2mg, 0.2mM) and methyl trifluroacetate (25.6 
mg, 0.2 mM) were added whilst stirring and the solution was 
stirred at room temperature for a further 10 hr. The methanol 
was then removed under vacuum. The residue was passed though 
a silica column with chloroform to give the required N-TFA-3- 
hydroxykynurenine methyl ester (20 mg, 60% yield).
TLC (B:A:W=4:2:1): Rf=0.8
MS: mw=334
lH NMR (CDCI3): 5 7.51 (d, 1H, J=8 NH), 7.20 (d, 1H, J=8, ), 6.77 (d, 
1H, J=8), 6.43 (t, 1H, J=8), 5.36 (s, 2H), 4.86 (m, 1H), 3.81-3.43 (m, 
2H), 3.71 (s, 3H).
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7.2.2 Preparation of 2 ,3 ,4 ,6-tetra-O - b e n z y l - D - g l u c o -  
pyranose  ( te trab en zy lg lu cose)
This compound was prepared according to the method of 
Glaudemans et al. (1972).
125g of powdered potassium hydroxide (2.23M) and 25g 
methyl-a-D-glucopyranoside (129mM) were added to a 75ml dry 
dioxane. While keeping the mixture boiling and stirring, 159ml of 
benzyl chloride was added in dropwise fashion over a 40min 
period and the same conditions were maintained for a further 30 
min to complete the reaction. Then the dioxane was distilled out 
slowly over a 3 hr period. The residue was cooled and the crystals 
formed were dissolved with sufficient water (500ml). This 
aqueous solution was extracted with 300ml ether. The separated 
ether phase was then washed twice with water (200ml each time) 
and dried in lOg anhydrous sodium sulphate. The dried ether 
phase was filtered though a layer of activated charcoal and then 
the ether was removed under vacuum. After the benzyl alcohol 
and dibenzyl ether, formed in the reaction, were removed on a 
200 °C oil bath under vacuum pump, 67.5g of crude product was 
obtained like light-yellow syrup (95% yield).
The syrup was dissolved in 1.25 L of hot glacial acetic acid 
on a steam bath. While boiling, 270ml hot 1M sulphuric acid was 
added. Then the mixture was kept on a steam bath for 2 hr, 
followed by addition of another 270ml of boiling 1M sulphuric 
acid. After the same conditions were maintained for 24 hr, the 
mixture was cooled and poured into 10L of water. The water 
solution was kept at 25°C for 2 days. After this time, the water
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was filtered out and the residue was dried and recrystallised from 
methanol. In the end, 48.7g pure 2,3,4,6-tetra-0 -benzy  1-D- 
glucopyranose white crystals were obtained with 70% yield.
M.P.: 143°C (literature 143°C).
1h  NMR: (CDCI3) 8 7.38-7.22(m,4x5H), 5.23, 5.22 (d, 1H, Cl, J=3.6), 
4.95-4.46 (m, 8H, 4 x O-CH^-Ph. and 2H, C6), 3.65-3.56 (m, 4H C-2, 
C-3, C-4, C-5).
7.2.3 Coupling of N-TFA-3-hydroxykynurenine methyl  
ester with 2 ,3 ,4 ,6 - t e t r a - o - b e n z y l - D - g lu c o p y r a n o s e
This preparation followed the method of Tsutsumi et al. 
(1981)
T etrabenzylglucose (540mg, ImM); dicyclohexyl 
carbodiimide (280mg, 1 mM) and copper(I) chloride (lmg, 
0.0ImM) were added to 5 ml chloroform. The solution was stirred 
at room temperature for 2 days, after which time the copper (I) 
chloride was washed out, first with 0.5 M aqueous ammonia 
solution (10 ml), and then with water(10 ml). The organic phase 
was dried with sodium sulphate. To this stirred chloroform 
solution, N-TFA-3-hydroxy kynurenine methyl ester (17mg, 
0.05mM) in 1 ml chloroform was added. The solution was kept 
stirring for another 2 days at room temperature after which time 
the solution was concentrated to 1 ml, and put though a silica 
column with chloroform as developing solvent to give N-TFA-3- 
hydroxykynurenine methyl ester tetrabenzylglucoside (30.5mg, 
70% yield) as a yellow white solid.
TLC (B:A:W:=4:2:1): Rf=0.7
68
! h  NMR (CDCI3): 5 7.31 (s, 5x5H), 6.6-6.5 (m, 3H), 5.16 (d, 1H, J=8), 
4.91-4.55 (m, 4x2H), 4.80 (m, 1H), 4.00 (m, 4H), 3.76 (s, 3H), 3.80­
3.60 (d, 2H, J=18).
7.2.4 Preparation of N-TFA-3-hydroxykynurenine methyl 
ester glucoside
N-TFA-3-hydroxykynurenine methyl ester tetrabenzyl- 
glucoside (17 mg, 0.02 mM) was added to 10 ml of glacial acetic 
acid which was dried over anhydrous cupric sulphate. Palladium 
on activated carbon (2 mg, 10%) was added as a catalyst and the 
solution was stirred under a hydrogen atmosphere for 15 hr. The 
catalyst was filtered out and the acetic acid was removed under 
vacuum.
The iH  NMR spectrum revealed the débenzylation reaction was 
unsuccessful.
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7.3. METHODS AND SYNTHESIS FOR THE COMPOUNDS OF 
SCHEME 2
7.3.1 Preparation of 3-hydroxy-2-nitroacetophenone
Preparation according to the method of Butenandt et al. 
(1957).
3-Hydroxyacetophenone (5g, 0.037mol) was dissolved in dry 
glacial acetic acid (30 ml) and acetic anhydride (4g, 0.039 mol) 
was added dropwise over 15 min at 10°C. The reaction mixture 
was stirred for 10 min and thereafter treated with cupric nitrate 
trihydrate (10g, 0.041 mol). Then the reaction mixture was cooled 
to 0°C and kept at this temperature for 2 hr, after which time the 
reaction mixture was poured into ice water (100ml). The solid 
formed was removed by filtration and dried, then redissolved in 
hot benzene (150ml). The mixture was recrystallised by 
concentrating to 70 ml, cooling slowly and then kept overnight to 
precipitate the undesired 3-hydroxy-6-nitroacetophenone. The 
mother liquor was further concentrated to approximately 10 ml to 
give the required isomer. The compound was redissolved in 
chloroform and passed through a silica column with chloroform as 
developing solvent to give pure 3-hydroxy-2-nitroacetophenone 
(0.54g, 8.12% yield) as a white yellow solid.
M.P.: 136 °C
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l U NMR (CDCI3): d 7.68-7.50 (d,d, 1H, J=9, C5), 7.26-7.14 (d,d, 1H, 
J5H-4H=9, J6H-4H=1.8, C4), 6.87-6.77 (d,d, 1H, J5H-6H=7.2, J4H- 
6H=1.8, C6), 2.51 (s, 3H, ).
7.3.2 Preparation of 2 ,3 ,4 ,6 - te tra a c e ty l -a -g lu co p y ra n o sy l  
b r o m i d e .
Preparation according to the method of Vogel’s Textbook of 
Practical Organic Chemistry, (Furniss, et a l , 1989. see page 647­
648).
20ml of acetic acid (212mM) was cooled to 4°C and while 
stirring, 0.12ml of 60% perchloric acid was added as a catalyst. 
After warming to the room temperature, 5g (28mM) dry 
powdered d-(+)-glucose was added in several portions while the 
temperature was maintained between 30-40°C. The mixture was 
cooled to 20°C and 1.6g (20mM) red phosphorus was added. In 
the following step, 2.9ml of bromine (9.1 g, 113mM) was added 
dropwise at a rate so that the temperature did not rise over 20°C. 
Lastly, 1.8ml of water was added over a period of 30 min. The 
reaction mixture was stirred at room temperature for about 2 hr, 
then diluted with 15ml dichloromethane. After this the mixture 
was transferred to a separating funnel, washing twice with iced 
water. The dichloromethane layer was drained to a big beaker 
containing a 150ml saturated solution of aqueous sodium 
hydrogen carbonate. When the evolution of carbon dioxide 
subsided, the dichloromethane layer was separated and dried in 
2g powdered silica gel. After filtering out the silica gel and 
removing out the dichloromethane, the crude product was
recrystallized twice from hexane-ether (50:50), the pure 
acetobromoglucose was obtained as white crystals.
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MP: 87°C (literature 88-89 °C).
iH  NMR (CDC13): 5 6.63, 6.58 (d,lH,), 5.67-5.46 (t, 1H), 5.26-5.05 
(t,lH), 4.9-4.75, (d,d, 1H), 4.28 (m, 3H), 2.09, 2.04, 2.03 (s,s,s, 
4xCOCH3).
7.3.3 Coupling of acetobrom oglucose with 3-hydroxy-2- 
n i t r o a c e to p h e n o n e .
Potassium carbonate (0.77g, 5.6 mM) was added to a stirred 
solution of 3-hydroxy-2-nitroacetophenone (0.5g, 2.8mM) in dry 
acetone (5mL) which was followed by adding dropwise 
acetobromoglucose (2.3g, 5.6mM) in dry acetone solution (5ml). 
The mixture was then stirred for 2 days at room temperature, 
after which time it was filtered to remove salt. Removal of solvent 
and recrystallisation from ether afforded pure 3-hydroxy-2- 
nitroacetoglucoside as a white solid.
M.P.: 168°C.
!h  NMR: (CDCI3) 5 7.53 (s.,3H, C-4, C-5, C-6), 5.21 (m, 4H, C-l\ C-2’, 
C-3', C-4'), 4.22 (d, 2H, CH2OAC, J=3.8), 3.89 (m, 1H, C-5’), 2.56 (s, 
3H), 2.11,2.07, 2.02, 2.01 (s,s,s,s,. 4 X COCH3).
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7.3.4 Preparation of a - B r o m o - 2 - n i t r o - 3 - h y d r o x y a c e t o -  
phenone te traacetog lucos ide
An excess of dioxane dibromide (1.2 equiv) was added to a 
solution of 2-nitro-3-hydroxy acetophenone tetraacetoglucoside 
(200mg) in dichloromethane (10ml), followed by ether (15ml). 
The solution was stirred for 6 hr. After TLC showed no more 
starting material, the solution was diluted with dichloromethane 
(50ml), and washed twice with saturated sodium hydrogen 
carbonate solution (40ml). The organic layer was dried (by 
Mg SO 4 ) and the dichloromethane was removed at 30-40° C . 
Recrystallisation from ethanol obtained a-bromo-2-nitro-3- 
hydroxy acetophenone tetraacetoglucoside as a white solid. 
(150mg, 66% yield).
M.P.: 144.5-145°C.
1h  NMR (CDCI3): 5 7.56 (m, 3H), 5.01-5.27 (m, 4H), 4.34 (d,lH, 
J=12.4Hz), 4.30 (1H, d, J=12.4Hz), 4.24 (d, 2H, J=3.7Hz), 3.85 (d,d,d,
1H, J=3.7, 3.7, 9.6Hz), 2.13, 2.09, 2.04, 2.03 (4xs, 12H).
13c NMR CDCI3): 5 188.93 (C), 170.44 (C), 170.11 (C), 169.30 (C), 
169.26 (C), 148.59 (C), 141.11 (C), 131.40 (CH), 128.72 (CH), 
124.35 (CH), 124.08 (CH), 100.34 (CH), 72.41 (CH), 72.08 (CH), 
70.28 (CH), 67.96 (CH), 61.62 (CH2), 30.83 (CH2), 20.44-20.67 
(CH3).
Microanalysis: C22H24BrNOl3. Found: C:44.54, H:3.96, N:2.37%
Required: C:44.75, H:4.07, N:2.37%
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7.3.5 Coupling a - b r o m o - 2 - n i t r o - 3 - h y d r o x y a c e t o p h e n o n e  
te traace tog lu cos id e  with ethy ln itroacetate
1.5 equivalents of ethylnitro-acetate (40mg, 0.3mM) was 
added to 1ml of dry DMF, followed by 1.0 equivalent of NaH 
(lOmg, 0.2mM). The solution was stirred at room temperature for 
10 min under a nitrogen atmosphere, after which time a-brom o- 
2-nitro-3-hydroxyacetophenone tetraacetoglucoside (118 mg, 0.2 
mM) in 1.0 ml dry DMF was added followed by 1.0 equivalent of 
AgC104 (42mg, 0.2mM)- The solution was stirred for 30 min, after 
which time the TLC showed no starting material remained, and 
several UV reactive spots had appeared on the TLC. The solution 
was diluted with 10 ml dichloromethane and washed with 10 ml 
1M HC1. The organic phase was dried by MgS04 and 
dichloromethane was evaporated. The residue was purified on a 
preparative TLC plate by developing with ethyl acetate/ 
dichloromethane (1:1). The spots were collected for NMR analysis. 
The NMR data showed the coupling reaction was unsuccessful.
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7.4. METHODS AND SYNTHESIS FOR THE COMPOUNDS OF 
SCHEME 3
7.4.1. Preparation of 3-hydroxykynurenine acetobromo-  
g l u c o s i de .
3-hydroxykynurenine (9mg, 0.03mM) was dissolved in 5 ml 
sodium carbonate/sodium hydrogen carbonate buffer (0.1 mM, 
pH10.5). The solution was stirred at room temperature for about 
10 min, after which time acetobromoglucose (41mg, O.lmM) in 5 
ml acetone was added dropwise over 4 hr under nitrogen. The 
solution was then stirred for another 4 hr. A new UV reactive spot 
appeared on TLC suggesting that this coupling reaction gives 3- 
hydroxykynurenine acetobromoglucoside.
MS (electrospray): MW=554 (MH+=555)
TLC (BAW) Rf=0.6
7.4.2. Preparation of 3-hydroxykynurenine glucoside.
Sodium hydroxide (400 mg, 10 mM) was added to the 
solution of 3-hydroxykynurenine acetobromoglucose. Then the 
solution was stirred for 3 hr at room temperature. After which 
time the solution was neutralised with concentrated hydrochloric 
acid and the acetone was removed under vacuum. The remaining 
solution was passed though an Alltech Maxi-clean Cl 8 cartridge
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and eluted with water. The fraction collected was dried on a 
Speedvac freeze drier and redissolved in the 20 mM HPLC buffer. 
HPLC was performed as described in general procedures (g) and 
the 15 min peak (3-hydroxykynurenine glucoside) was collected. 
After the sample was dried on the Speedivac freeze drier, it was 
chromatographed through a Sephadex column equilibrated in 
water (35 X 1.2cm; flow rate 5 ml/hr) for purification and to 
remove the HPLC buffer salt. The water was evaporated under 
vacuum to give pure 3-hydroxykynurenine glucoside (3 mg 20% 
yield) as a brown-yellow solid.
TLC (BAW); Rf=0.2
MS (electrospray): Theoretical MW=386 (MH+=387)
*H NMR (D20): 5 7.48, 7.47 (d, 1H), 7.18, 7.16 (d, 1H), 6.61, (t, 1H), 
4.90, 4.89 (d, 1H), 3.78, 3.74 (d,d, 1H), 3.61, 3.58 (d,d,2H), 3.46 (m, 
4H), and 3.38, 3.36 (d,d, 2H).
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7.5. METHODS FOR TRYPSIN AND CARBOXYPEPTIDASE A 
DIGESTION.
7 . 5 . 1  Carboxypeptidase  A and trypsin digestion of  
polypeptides A (model experiment for pb2 crystallin)
Polypeptide A (M-Q-W-H-Q-R-Q-A-F-H-P-S-S 192-204), 
corresponding to the C-terminus of bovine PB2 crystallin, (lmg, 
0.63mM) was dissolved in 1ml 0.1 M NH4HCO3 , O.lmM CaCl2 
buffer (pH=8.1) and carboxypeptidase A (1% by weight of the 
polypeptide A) in 2M NH4H C O 3 was added. Before use, the 
carboxypeptidase A was washed twice with water to remove 
contaminating amino acids and dissolved in 10ml 2M NH4HCO3 . 
The mixture was then incubated in a 37°C water bath for 1 hour. 
After that period TPCK treated trypsin purchased from Sigma (1% 
by weight of the polypeptide A) in O.lmM HC1 was added. The 
mixture was incubated at 37 °C again for 10 min. Lastly, 1ml 5% 
TFA water was added to stop the enzyme digestion. The digested 
polypeptide A solution was kept in the freezer (-20 °C) until HPLC 
and CE analysis.
7.5.2. Trypsin digest P B2cry  s ta l l i n
4mg of pB2 crystallin was dissolved in 1ml of 0.1 M 
NH4HCO3, O.lmM CaCl2 buffer (pH=8.1), followed by addition of 
TPCK treated trypsin (1% by weight of the pB2 crystallin) which 
was in O.lmM HC1. The mixture was incubated in a water bath at 
37°C for 10 min. After which time, 1ml 5% TFA water was added
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to stop the tryptic digest. The mixture was transferred to two 
small Eppendof tubes and centrifuged for 10 min to remove the 
precipitated protein. The supernatant was collected and kept in 
freezer (-20 °C) for HPLC separation.
7.5.3. Optimization of HPLC conditions for the tryptic pB 2 
C-terminal residues purification
A C-18 reverse phase HPLC column was chose for the pB2 C- 
terminal residue purification, acetonitrile and water were 
selected as the mobile phase while different gradient programme 
were tested. The optimization is only concentrated on the 
selection of gradient programme. The optimal HPLC conditions are 
as follows:
Buffer A: Milli Q water with 0.05% TFA (trifluoroacetic acid).
Buffer B: 50% acetonitrile:50% Milli Q water with 0.05 %TFA
Gradient programme: 100% buffer A to 50% buffer B in 60 
minutes.
Flowrate: 0.8ml/min
Detector wavelength: 229 or 280nM.
Each time the HPLC was turned on, a standard sample of 
carboxypeptidase A and trypsin digested synthetic model C- 
terminal polypeptide was used to calibrate the column. 
Purification of trypsin digested foetal and old pB2 crystallin 
samples was then carried out. Peaks with the same retention
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times as the model serine loss and normal sequence of the tryptic 
C-terminal polypeptides were collected and freeze dried for CE 
and electrospray MS analysis.
7.5.4. Optimization of CE Conditions for tryptic C-
terminal peptides Analysis
In this experiment, an ISCO model 3850 capillary 
electrophoresis system with a fixed length ISCO CE capillary 
column (50mm x 84cm) was used. The optimization of CE 
conditions is concentrated on the selection of electrolyte buffer 
and adjustment of suitable high voltage value.
Five peptide samples (1. L-Phe-Ala-Gly-Gly; 2. L-Ala-Ala- 
Ala; 3. N-Acetyl-Ala-Ala-Ala; 4. Tyr-Gly-Gly and 5. Hexaglycine) 
were used as standard for the selection of electrolyte buffer. Four 
electrolyte buffer system were tested;
1. 40mM ammonium acetate buffer, adjust pH to 6.5 with 
acetic acid.
2. 20mM Na2HP04/NaH2P04 buffer pH=8;
3. 40mM Tri-sodium citrate buffer, adjust pH to 7 with 
80mM citric acid.
4. 0.1M Tricine and 0.02M morpholine buffer, adjust pH to 
8.1 with 0.1M HC1 or 0.1M NaOH.
While test each electrolyte buffer with the five peptides, 
different high voltage from 10 to 30 kV were tried. In the end,
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the optimum CE conditions for analysis of C-terminals residue 
were:
Electrolyte Buffer: 1M Tricine and 0.02M morpholine buffer, 
adjust pH to 8.1 with 0.1M HC1 or 0.1M NaOH;
High Voltage: 10 kV;
Detector Wavelength: 210 nM.
The analysis was performed at room temperature.
ppm
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